Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 625

1.

Genetic variants associated with non-typhoidal Salmonella bacteraemia in African children.

Gilchrist JJ, Mills TC, Naranbhai V, Chapman SJ, Fairfax BP, Knight JC, Williams TN, Scott JA, MacLennan CA, Rautanen A, Hill AV; The Wellcome Trust Case Control Consortium 2.

Lancet. 2015 Feb 26;385 Suppl 1:S13. doi: 10.1016/S0140-6736(15)60328-2.

PMID:
26312835
2.

Profiling the host response to malaria vaccination and malaria challenge.

Dunachie S, Hill AV, Fletcher HA.

Vaccine. 2015 Aug 6. pii: S0264-410X(15)01116-0. doi: 10.1016/j.vaccine.2015.07.107. [Epub ahead of print]

3.

Transcriptional changes induced by candidate malaria vaccines and correlation with protection against malaria in a human challenge model.

Dunachie S, Berthoud T, Hill AV, Fletcher HA.

Vaccine. 2015 Aug 6. pii: S0264-410X(15)01065-8. doi: 10.1016/j.vaccine.2015.07.087. [Epub ahead of print]

4.

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.

Jones AG, McDonald TJ, Shields BM, Hill AV, Hyde CJ, Knight BA, Hattersley AT; PRIBA Study Group.

Diabetes Care. 2015 Aug 4. pii: dc150258. [Epub ahead of print]

PMID:
26242184
5.

Genomic modulators of gene expression in human neutrophils.

Naranbhai V, Fairfax BP, Makino S, Humburg P, Wong D, Ng E, Hill AV, Knight JC.

Nat Commun. 2015 Jul 7;6:7545. doi: 10.1038/ncomms8545.

6.

Comparative assessment of vaccine vectors encoding ten malaria antigens identifies two protective liver-stage candidates.

Longley RJ, Salman AM, Cottingham MG, Ewer K, Janse CJ, Khan SM, Spencer AJ, Hill AV.

Sci Rep. 2015 Jul 3;5:11820. doi: 10.1038/srep11820.

7.

Genetic susceptibility to invasive Salmonella disease.

Gilchrist JJ, MacLennan CA, Hill AV.

Nat Rev Immunol. 2015 Jun 25;15(7):452-63. doi: 10.1038/nri3858.

PMID:
26109132
8.

Comparative assessment of transmission-blocking vaccine candidates against Plasmodium falciparum.

Kapulu MC, Da DF, Miura K, Li Y, Blagborough AM, Churcher TS, Nikolaeva D, Williams AR, Goodman AL, Sangare I, Turner AV, Cottingham MG, Nicosia A, Straschil U, Tsuboi T, Gilbert SC, Long CA, Sinden RE, Draper SJ, Hill AV, Cohuet A, Biswas S.

Sci Rep. 2015 Jun 11;5:11193. doi: 10.1038/srep11193.

9.

Deletion of Fifteen Open Reading Frames from Modified Vaccinia Virus Ankara Fails to Improve Immunogenicity.

Alharbi NK, Spencer AJ, Hill AV, Gilbert SC.

PLoS One. 2015 Jun 8;10(6):e0128626. doi: 10.1371/journal.pone.0128626. eCollection 2015.

10.

Design, recruitment, and microbiological considerations in human challenge studies.

Darton TC, Blohmke CJ, Moorthy VS, Altmann DM, Hayden FG, Clutterbuck EA, Levine MM, Hill AV, Pollard AJ.

Lancet Infect Dis. 2015 Jul;15(7):840-51. doi: 10.1016/S1473-3099(15)00068-7. Epub 2015 May 27. Review.

PMID:
26026195
11.

Variants in the Mannose-binding Lectin Gene MBL2 do not Associate With Sepsis Susceptibility or Survival in a Large European Cohort.

Mills TC, Chapman S, Hutton P, Gordon AC, Bion J, Chiche JD, Holloway PA, Stüber F, Garrard CS, Hinds CJ, Hill AV, Rautanen A; ESICM/ECCRN GenOSept Investigators.

Clin Infect Dis. 2015 Sep 1;61(5):695-703. doi: 10.1093/cid/civ378. Epub 2015 May 12.

12.

Searching for the human genetic factors standing in the way of universally effective vaccines.

Mentzer AJ, O'Connor D, Pollard AJ, Hill AV.

Philos Trans R Soc Lond B Biol Sci. 2015 Jun 19;370(1671). pii: 20140341. doi: 10.1098/rstb.2014.0341. Review.

PMID:
25964463
13.

Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.

Ellis MK, Elliott KS, Rautanen A, Crook DW, Hill AV, Chapman SJ.

PLoS One. 2015 Apr 17;10(4):e0123532. doi: 10.1371/journal.pone.0123532. eCollection 2015.

14.

Induction of CD8(+) T cell responses and protective efficacy following microneedle-mediated delivery of a live adenovirus-vectored malaria vaccine.

Pearson FE, O'Mahony C, Moore AC, Hill AV.

Vaccine. 2015 Jun 22;33(28):3248-55. doi: 10.1016/j.vaccine.2015.03.039. Epub 2015 Apr 1.

PMID:
25839104
15.

Development of an in vitro assay and demonstration of Plasmodium berghei liver-stage inhibition by TRAP-specific CD8+ T cells.

Longley RJ, Bauza K, Ewer KJ, Hill AV, Spencer AJ.

PLoS One. 2015 Mar 30;10(3):e0119880. doi: 10.1371/journal.pone.0119880. eCollection 2015.

16.

Corrections. Emergency Ebola response: a new approach to the rapid design and development of vaccines against emerging diseases.

Tully CM, Lambe T, Gilbert SC, Hill AV.

Lancet Infect Dis. 2015 Mar;15(3):263. doi: 10.1016/S1473-3099(14)70967-3. Epub 2015 Jan 20. No abstract available.

PMID:
25749220
17.

Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.

Walters AA, Krastev C, Hill AV, Milicic A.

J Pharm Pharmacol. 2015 Mar;67(3):400-8. doi: 10.1111/jphp.12367. Epub 2015 Feb 2.

PMID:
25644530
18.

A Monovalent Chimpanzee Adenovirus Ebola Vaccine - Preliminary Report.

Rampling T, Ewer K, Bowyer G, Wright D, Imoukhuede EB, Payne R, Hartnell F, Gibani M, Bliss C, Minhinnick A, Wilkie M, Venkatraman N, Poulton I, Lella N, Roberts R, Sierra-Davidson K, Krähling V, Berrie E, Roman F, De Ryck I, Nicosia A, Sullivan NJ, Stanley DA, Ledgerwood JE, Schwartz RM, Siani L, Colloca S, Folgori A, Di Marco S, Cortese R, Becker S, Graham BS, Koup RA, Levine MM, Moorthy V, Pollard AJ, Draper SJ, Ballou WR, Lawrie A, Gilbert SC, Hill AV.

N Engl J Med. 2015 Jan 28. [Epub ahead of print]

19.

The relative magnitude of transgene-specific adaptive immune responses induced by human and chimpanzee adenovirus vectors differs between laboratory animals and a target species.

Dicks MD, Guzman E, Spencer AJ, Gilbert SC, Charleston B, Hill AV, Cottingham MG.

Vaccine. 2015 Feb 25;33(9):1121-8. doi: 10.1016/j.vaccine.2015.01.042. Epub 2015 Jan 25.

20.

Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies.

Hodgson SH, Douglas AD, Edwards NJ, Kimani D, Elias SC, Chang M, Daza G, Seilie AM, Magiri C, Muia A, Juma EA, Cole AO, Rampling TW, Anagnostou NA, Gilbert SC, Hoffman SL, Draper SJ, Bejon P, Ogutu B, Marsh K, Hill AV, Murphy SC.

Malar J. 2015 Jan 28;14:33. doi: 10.1186/s12936-015-0541-6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk